Dobutamine increases oxygen consumption during constant flow cardiopulmonary bypass

Area of Science:

• Cardiovascular Physiology
• Critical Care Medicine

Background:

• Cardiopulmonary bypass (CPB) requires careful management of systemic hemodynamics and oxygen transport.
• Understanding the interplay between flow, oxygen delivery (DO2), and oxygen consumption (VO2) is crucial during CPB.
• Mild hypothermia is often employed during CPB, potentially affecting physiological responses.

Purpose of the Study:

• To investigate the distinct effects of increasing CPB flow versus dobutamine administration on systemic hemodynamics, DO2, and VO2.
• To assess the impact of these interventions on gastric microcirculatory blood flow (MCF) during CPB.
• To determine if dobutamine-induced increases in VO2 are dependent on systemic blood flow.

Main Methods:

• Studied 20 patients undergoing CPB with mild hypothermia (34°C).
• Measured systemic hemodynamic variables, DO2, and VO2.
• Assessed gastric MCF using laser Doppler flowmetry in a subgroup of 7 patients.
• Interventions included increasing CPB flow (2.4 to 3.0 L/min/m²) and infusing dobutamine (6 µg/kg/min) during constant flow CPB.

Main Results:

• Increasing CPB flow significantly increased DO2 (27%), mean arterial pressure, and MCF, but did not alter VO2.
• Dobutamine infusion during constant flow CPB significantly increased VO2 (11%) without changing DO2 or MCF.
• No significant differences were observed in baseline DO2, VO2, or hemodynamic variables between intervention periods.

Conclusions:

• Increased CPB flow enhances oxygen delivery but does not necessarily increase oxygen consumption.
• Dobutamine effectively increases oxygen consumption during CPB, independent of changes in systemic flow.
• These findings suggest that dobutamine's mechanism for increasing VO2 during CPB may not rely on augmented systemic blood flow.